FOSTER CITY, Nov. 2 /PRNewswire/ -- Biotechnology stocks are broadly
resurgent again, and the drug-delivery group is no exception. The Third
Annual Informed Investors Bay Area Drug Delivery Stocks Forum on November 18
offers investors a full update on companies in this group.
The Forum features companies like Aradigm (Nasdaq: ARDM) and
Bioject Medical Technologies, Inc. (Nasdaq: BJCT), which are developing
alternatives for conventional, needle delivery. It also gives investors a
broad look at the group, from inhaleable-insulin developer
Inhale Therapeutics (Nasdaq: INHL) with a market capitalization of
$2.3 billion, to tiny, emulsion-delivery firm Sonus, sporting a $6 million
The Forum runs from 8:30 a.m. to 12:30 p.m. Saturday, November 18 at the
Crowne Plaza Hotel in Foster City. The cost is $25 prepaid, $40 at the door.
More information and registration can be found at www.InformedInvestors.com or
by calling 800-992-4683.
Aradigm Corporation is a developer of advanced pulmonary drug delivery
systems for the treatment of systemic conditions as well as lung diseases.
Aradigm's principal product development programs are based on its AERx
Pulmonary Drug Delivery System, which creates aerosols from liquid drug
formulations for delivery locally to the lung or systemically via the lung.
Inhale, located in San Carlos, Calif., is pioneering drug delivery systems
to deliver easily a range of inhaleable drugs. Inhale now has four partnered
development projects that are in clinical testing. They are inhaleable forms
of drugs used to treat diabetes, multiple sclerosis, osteoporosis and
Bioject Medical Technologies Inc. develops, manufactures and markets jet
injection systems for needle-free drug delivery. Bioject's two core products
are the Biojector 2000 and the Vitajet. The Biojector 2000 system is a CO2
cartridge that delivers doses of medication through the skin. The Vitajet
serves a similar function as the Biojector, but is powered by a spring rather
InformedInvestors.com is the conduit for unfiltered communication between
individual investors and the executives of technology and biotechnology
companies. Live virtual and onsite Forums, special webcasts, original
editorial pieces and widely followed weekly radio shows, "BioTalk" and "Tech
Check," put individual investors in the analyst's chair.
/CONTACT: Brian Finnigan or Steve Chanecka, both of
InformedInvestors.com, 916-780-6100, or 800-992-4683/
/Web site: http://www.informedinvestors.com/
(INHL ARDM BJCT)
CO: InformedInvestors.com; Aradigm Corporation; Bioject Medical Technologies,
Inc.; Inhale Therapeutics
IN: FIN MLM BIO
-0- Nov/02/2000 20:59 GMT
Press spacebar to pause and continue. Press esc to stop.